News and Updates

The FDA approved Zegalogue® (dasiglucagon) injection, for the treatment of severe hypoglycemia in children and adults with diabetes aged 6 and above.

Normally, the kidneys filter waste and extra water out of your blood to make urine. When your kidneys are damaged, they can’t filter blood like they should.

Vertex Pharmaceuticals will launch a clinical trial of VX-880, a stem cell-derived beta cell therapy in type 1 diabetes (T1D).

It’s been a tough year, to say the least. But there’s news that we can be proud of in type 1 diabetes research and advocacy. Really proud of.

“We’ve been too focused on [insulin],” Jeremy Pettus, M.D., an endocrinologist at UC San Diego, says. Watch the video to find out why.

In 1974, two teams showed that diabetes is associated with antibodies against beta cells, which helped establish T1D as an autoimmune disease.

Leading researchers gathered, virtually, for the EASD Annual Meeting, and featured more than 40 studies presented by Breakthrough T1D researchers.

The common belief for decades was that diligent monitoring of blood sugars and intensive insulin therapy had little consequence for people with diabetes. Then the Diabetes Control and Complications Trial (DCCT) took place. This trial, from 1983-1993, would find out if intensive insulin control warded off complications from the disease. (Hint: it does.) A lot […]

In the words of Colin Dayan, M.D., Ph.D., professor of clinical diabetes and metabolism at Cardiff University: “Type 1 diabetes is almost the only major autoimmune disease now that does not have a licensed immunotherapy.” And he’s going to change that.

A clinical trial at four pediatric diabetes centers in the United States has found that a new artificial pancreas system—which automatically monitors and regulates blood-sugar levels—is safe and effective in children as young as age six with type 1 diabetes (T1D): Tandem’s t:slim X2™ insulin pump with Control-IQ™ technology. The algorithm in the Control-IQ technology […]